Skip to main content
logo
Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
12.24
-0.57 (-4.45%)
Sep 18, 2026, 4:00 PM EDT - Market closed

Design Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
7665343491485731,183
Market Cap Growth
126.06%52.95%135.41%-74.10%-51.55%-
Enterprise Value
56133098-139233793
Last Close Price
12.249.386.172.6510.2621.41

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
3.792.511.440.531.753.10
P/TBV Ratio
3.792.511.440.531.753.10

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.010.010.010.010.01
Net Debt / Equity Ratio
-1.01-1.03-1.00-1.00-1.00-1.00
Net Debt / EBITDA Ratio
2.612.783.943.594.8610.66
Net Debt / FCF Ratio
3.714.005.604.746.2512.31
Quick Ratio
18.6116.9729.1629.4430.7672.72
Current Ratio
18.8617.1429.3129.5831.1072.96
Return on Equity (ROE)
-34.13%-30.70%-19.08%-22.10%-17.85%-17.08%
Return on Assets (ROA)
-22.53%-20.66%-14.39%-15.50%-11.55%-10.49%
Return on Capital Employed (ROCE)
-38.70%-37.10%-25.60%-27.90%-20.50%-9.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-9.24%-13.06%-14.19%-45.05%-11.05%-3.00%
FCF Yield
-7.20%-10.21%-12.44%-39.63%-9.12%-2.61%
Buyback Yield / Dilution
-5.61%-1.31%-1.08%-0.50%-21.27%-190.80%
SEC Filings: 10-K · 10-Q